HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antithrombin Rybnik: a new point mutation (nt 683 G>T) associated with type I antithrombin deficiency in a patient with venous thromboembolism and recurrent superficial venous thrombosis.

AuthorsMagdalena Szymańska, Martine Alhenc-Gelas, Anetta Undas
JournalBlood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis (Blood Coagul Fibrinolysis) Vol. 24 Issue 5 Pg. 579-80 (Jul 2013) ISSN: 1473-5733 [Electronic] England
PMID23807486 (Publication Type: Case Reports, Letter)
Chemical References
  • SERPINC1 protein, human
  • Antithrombin III
Topics
  • Adult
  • Antithrombin III (genetics)
  • Antithrombin III Deficiency (genetics)
  • Cesarean Section (adverse effects)
  • Female
  • Humans
  • Point Mutation (genetics)
  • Poland
  • Recurrence
  • Venous Thromboembolism (genetics)
  • Venous Thrombosis (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: